Treatment of Alopecia

Treatment of Alopecia with Regenerative Cell Therapy. This case demonstrates the effectiveness of regenerative cell therapy in promoting hair regrowth and addressing alopecia in patients who have not responded adequately to conventional treatments. By targeting hair follicle regeneration and improving scalp microcirculation, regenerative therapy offers new hope for individuals seeking effective management of alopecia. Further research and clinical studies are warranted to validate these findings and optimize treatment protocols for alopecia.

Patient Information:

Age 59 years old

Gender Female

Ethnicity White

Medical History:

No allergies or genetic diseases. Moderate alcohol consumption (3-4 drinks per week), daily coffee intake (2-3 cups/day), and received multiple vaccines with boosters since childhood. Currently taking Rinvoq for the past 2 years to slow hair loss.

Presenting Complaint:

She presented with alopecia, a condition characterized by hair loss, despite being on Rinvoq, which had slowed but not reversed the progression of her hair loss. She sought treatment to address her alopecia and improve hair regrowth.

Treatment Approach:

In pursuit of hair regrowth, she opted for regenerative cell therapy. Over the course of four months, she underwent four treatment sessions, each consisting of six units of complete regenerative cell factors. The treatment was administered via intravenous infusion, subcutaneous injections, and topical application by micro-channel.

Clinical Course:

Following the completion of the four-month treatment protocol, she experienced noticeable improvements in her hair regrowth. The regenerative cell therapy targeted the underlying factors contributing to alopecia, including promoting hair follicle regeneration and improving scalp microcirculation.

Before and After Treatment

Follow-Up:

She continued to monitor her hair regrowth progress following the completion of the treatment protocol. Regular assessments confirmed sustained improvements in hair density and quality, supporting the long-term efficacy of the regenerative cell therapy.

Conclusion:

This case demonstrates the effectiveness of regenerative cell therapy in promoting hair regrowth and addressing alopecia in patients who have not responded adequately to conventional treatments. By targeting hair follicle regeneration and improving scalp microcirculation, regenerative therapy offers new hope for individuals seeking effective management of alopecia. Further research and clinical studies are warranted to validate these findings and optimize treatment protocols for alopecia.